tiprankstipranks
Trending News
More News >

Medicenna Showcases Promising Results and Strong Financials

Story Highlights
Medicenna Showcases Promising Results and Strong Financials

Medicenna Therapeutics Corp (TSE:MDNA) has released an update.

Confident Investing Starts Here:

Medicenna Therapeutics Corp reported promising results from its ABILITY-1 study, showcasing the potential of its MDNA11 Superkine to enhance cancer treatment, particularly in patients resistant to existing therapies. The company also highlighted a strong financial position with $30 million in cash and projected milestones for 2025, fueling investor confidence. These developments underscore Medicenna’s innovative approach and potential impact on the immunotherapy market.

For further insights into TSE:MDNA stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1